Literature DB >> 15305404

Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome.

Sten Holmäng1, Sonny L Johansson.   

Abstract

BACKGROUND: Synchronous bilateral urothelial tumors of the upper urinary tract are very rare. The authors reported baseline and long-term follow-up data for all patients in western Sweden during a 28-year period.
METHODS: The authors performed a clinical and histopathologic study of all patients in western Sweden who were diagnosed with a malignant neoplasm in the renal pelvis or ureter between 1971 and 1998.
RESULTS: Of 936 patients, 15 (1.6%) had synchronous bilateral tumors. The incidence of such tumors decreased in each successive decade. Abuse of phenacetin-containing analgesics by patients also decreased during the study period, as did the incidence of renal papillary necrosis. The median age at diagnosis of bilateral tumors was 68 years, and 80% of the patients were male. Eleven patients had bilateral tumors of the renal pelvis, two had bilateral ureteral tumors, and two had tumors of the renal pelvis and contralateral ureter. Partial renal pelvic, ureteral, or kidney resection on at least one side was possible in eight patients, and four patients were left untreated on at least one side. Only three patients underwent bilateral nephroureterectomy. Twelve patients (80%) had bladder carcinoma diagnosed either before or after diagnosis of the upper tract tumors. The median survival period for the 11 patients who received surgery for their bilateral tumors was 84 months.
CONCLUSIONS: The decreasing incidence of synchronous bilateral upper tract tumors may be related to the prohibition of phenacetin-containing analgesics in the 1960s. Partial resection with preservation of the renal parenchyma was possible in the majority of patients. Survival for patients with bilateral tumors did not differ from that of patients with unilateral tumors. Copyright 2004 American Cancer Society.

Entities:  

Mesh:

Year:  2004        PMID: 15305404     DOI: 10.1002/cncr.20395

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  [Diagnostic procedures in upper urinary tract urothelial carcinoma].

Authors:  O Patschan; M Horstmann; C Thomas; H P Schlemmer; A Stenzl
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

2.  A patient with synchronous bilateral low-grade upper tract urothelial carcinoma who underwent nephroureterectomy and total ureterectomy with ileal ureteric replacement.

Authors:  Yoshinori Matsuda; Takamitsu Inoue; Atsushi Maeno; Atsushi Koizumi; Ryohei Yamamoto; Taketoshi Nara; Sohei Kanda; Kazuyuki Numakura; Mitsuru Saito; Shintaro Narita; Shigeru Satoh; Tomonori Habuchi
Journal:  Int Cancer Conf J       Date:  2020-03-03

3.  Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer.

Authors:  Chien-Hui Ou; Wen-Horng Yang
Journal:  Int Urol Nephrol       Date:  2017-02-04       Impact factor: 2.370

4.  Treatment strategies for upper tract urothelial carcinoma (UTUC) of a solitary kidney: a single-institutional analysis of 61 cases.

Authors:  Xiaohong Su; Dong Fang; Lei Zhang; Gengyan Xiong; Han Hao; Guangzhi Zhao; Kunlin Yang; Yunchao Xing; Xuesong Li; Liqun Zhou
Journal:  Int Urol Nephrol       Date:  2016-07-04       Impact factor: 2.370

5.  A clinical study on surgical causes of Hematuria.

Authors:  Kewithinwangbo Newme; Ranendra Hajong; Ratna Kanta Bhuyan
Journal:  J Family Med Prim Care       Date:  2021-01-30

6.  Single-session laparoscopic cystectomy and nephroureterectomy.

Authors:  Marcin Słojewski; Piotr Chłosta; Marek Myślak; Grzegorz Herlinger; Piotr Dobroński; Piotr Kryst; Tomasz Drewa
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2012-11-26       Impact factor: 1.195

7.  Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients.

Authors:  Dong Fang; Pei Liu; Xuesong Li; Gengyan Xiong; Lei Zhang; Nirmish Singla; Guangzhi Zhao; Qun He; Zhisong He; Liqun Zhou
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

Review 8.  Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma.

Authors:  Firas G Petros
Journal:  Transl Androl Urol       Date:  2020-08

Review 9.  Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives.

Authors:  Jeffrey J Leow; Zhenbang Liu; Teck Wei Tan; Yee Mun Lee; Eu Kiang Yeo; Yew-Lam Chong
Journal:  Onco Targets Ther       Date:  2020-01-06       Impact factor: 4.147

10.  Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma.

Authors:  Kajsa M Ericson; Anna P Isinger; Björn L Isfoss; Mef C Nilbert
Journal:  BMC Cancer       Date:  2005-03-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.